Resources

Blood glucose levels measured in hospitalized patients during acute illness predicted the risk of developing type 2 diabetes in the following three years…. 

BIOD-531 is a new ultra-rapid-acting insulin formulation that has been shown to work better than current therapies at treating diabetes in a mid-stage trial…. 

A randomized controlled trial indicates that a vegan diet may be beneficial in relieving diabetic nerve pain…. 

Developed by Taiwanese researchers, the device can hang on a pair of glasses and is called a "pupillometer." … 

Younger age groups may be at higher risk in developing complications, possibly due to later addition of statin medications….

Renal abnormalities may be indicated by a specific key marker in type 2 diabetes…. 

Not all saturated fatty acids are the same in relation to type 2 diabetes risk….

In this last of a comprehensive series of four Homerun Slides sets on SGLT-2 inhibitors, we delve deeper into how this drug class can work in challenging patient populations, incuding older and renally-impaired patients. In addition, the beneficial effects on weight and blood pressure are discussed…. To download the complete …

In this third set of a series of four Homerun Slides on SGLT-2 inhibitor medications, we cover LX4211, an SGLT-1 and SGLT-2 dual inhibitor, and then explore some of the safety concerns around SGLT-2 inhibitors including the safety of this drug class for older patients. We also review some of …

In this second set of a comprehensive four-part series of Homerun Slides on SGLT-2 inhibitors, we review some of the data of the second and third approved SGLT-2 inhibitors in the U.S., dapagliflozin (Farxiga) and empagliflozin (Jardiance), along with the Durability and Limitations of this drug class…. To download this …